DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 2,810.00
+115.00 (4.27%)
Jun 11, 2026, 12:34 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 86.2 billion as of June 10, 2026. Its market cap has decreased by -42.54% in one year.
Market Cap
86.20B
Enterprise Value
117.29B
Revenue
128.38B
Ranking
n/a
PE Ratio
9.91
Stock Price
2,810.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 86.20B, a decrease of -56.98%. That is a compound annual growth rate of -47.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 86.20B | -26.37% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.99T |
| Celltrion | 36.82T |
| ALTEOGEN | 17.49T |
| Samsung Epis Holdings | 10.48T |
| Access Bio | 91.28B |
| Amicogen | 89.33B |
| LabGenomics | 85.90B |
| Osang Healthcare Co.,Ltd | 85.78B |